Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro

Drug Metabolism and Disposition

Volumn 29, Issue 6, 2001, Pages 897-902

  Zhang, Wenjiang ^a   Kilicarslan, Tansel ^a   Tyndale, Rachel F ^a,c   Sellers, Edward M ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENOL; COUMARIN; CYTOCHROME P450 2A6; DEXTROMETHORPHAN; DICLOFENAC; METHOXSALEN; NICOTINE; OMEPRAZOLE; PHENACETIN; TRANYLCYPROMINE; TRYPTAMINE;

ARTICLE; DRUG USE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; HUMAN; HUMAN TISSUE; LIVER MICROSOME; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE;

ARYL HYDROCARBON HYDROXYLASES; CELLS, CULTURED; COTININE; CYTOCHROME P-450 ENZYME SYSTEM; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; HUMANS; METHOXSALEN; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; NICOTINE; TRANYLCYPROMINE; TRYPTAMINES;

EID: 0035024678     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Andersson T, Miners JO, Veronese ME and Birkett DJ (1994) Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism. Br J Clin Pharmacol 37:597-604.
2. Bourrie M, Meunier V, Berger Y and Fabre G (1996) Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J Pharmacol Exp Ther 77:321-332.
3. Crespi CL, Penman BW, Gelboin HV and Gonzalez FJ (1991) A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 2:1197-1201.
4. Draper AJ, Madan A and Parkinson A (1997) Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Arch Biochem Biophys 41:47-61.
5. Eagling VA, Tjia JF and Back DJ (1998) Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Br J Clim Pharmacol 5:107-114.
6. Ekins S. VandenBranden M and Ring BJ, Wrighton SA (1997) Examination of purported probes of human CYP2B6. Pharmacogenetics 7:165-179.
7. Hampson DR, Baker GB and Courts RT (1986) A comparison of the neurochemical properties of the stereoisomers of tranylcypromine in the central nervous system. Cell Mol Biol 32:593-599.
8. Hecht SS and Hoffmann D (1988) Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9:875-884.
9. Henningfield JE, Miyasato K and Jasinki DR (1985) Abuse liability and Pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234:1-12.
10. Hichman D, Wang JP, Wang Y and Unadkat JD (1998) Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug Metab Dispos 26:207-215.
11. Kharasch ED, Hankins DC and Taraday JK (2000) Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity. Drug Metab Dispos 28:28-33.
12. Koenigs LL, Peter RM, Thompson SJ, Rettie AE and Trager WF (1997) Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metab Dispos 25:1407-1415.
13. Leemann T. Transon C and Dayer P (1993) Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver. Life Sci 52:29-34.
14. Lewis DFV and Lake BG (1995) Molecular modeling of members of the P4502A subfamily: application to studies of enzyme specificity. Xenobiotica 25:585-598.
15. Li Y, Li N-Y and Sellers EM (1997) Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes. Eur J Drug Metab Pharmacokinet 22:295-304.
16. Maenpaa J, Juvonen R, Raunio H, Rautio A and Pelkonen O (1994) Metabolic interactions of methoxsalen and coumarin in human and mice. Biochem Pharmacol 48:1363-1369.
17. Maenpaa J, Sigusch H, Raunio H, Syngelma T, Vuorela P. Vuorela H and Pelkonen O (1993) Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem Pharmacol 45:1035-1042.
18. Mallinger AG and Edwards DJ (1986) Pharmacokinetics of tranyleypromine in patients who are depressed: relationship to cardiovascular effects. Clin Pharmacol Ther 40:444-450.
19. Messina ES, Tyndale RF and Sellers HM (1997) A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 282:1608-1614.
20. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T and Kuroiwu Y (1996) Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24:1212-1217.
21. Ono S, Hatanaka T, Hotta H, Atoh T, Gonzalez FJ and Tsutsui M (1996) Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 26:681-693.
22. Oscarson M, McLellan RA, Gullsten H, Yue QY, Lang MA, Bernal ML, Inues B, Hirvonen A, Raunio H, Pelkonen O and Ingelman-Sundberg M (1999) Characterization and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Lett 448:105-110.
23. Otton SV, Wu D, Joffe RT and Sellers EM (1993) Inhibition by fluoxetine of cytochrome P450 2D6 activity. Clin Pharmacol Ther 53:401-409.
24. Pianezza ML, Sellers EM and Tyndale RF (1998) Nicotine metabolism defect reduces smoking. Nature (Lond) 393:750.
25. Rao Y, Hoffmann E, Zia M, Bodin L, Zeman M, Sellers EM and Tyndale RF (2000) Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. Mol Pharmacol 58:747-755.
26. Sabol SZ and Hamer DH (1999) An improved assay shows no association between the CYP2A6 gene and cigarette smoking. Behav Genet 29:257-261.
27. Sellers EM, Zeman MV, Kaplan HL and Tyndale RF (2000) Inhibition of cytochrome P450 2A6 (CYP2A6) decreases smoking and activation of the procarcinogen 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK). Clin Pharmacol Ther 67:113.
28. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemical studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
29. Spahn-Langguth H, Hahn G, Mutschler E, Mohrke W and Langguth P (1992) Enantiospecific high-performance liquid chromatographic assay with fluorescence detection for the monoamine oxidase inhibitor tranylcypromine and its applicability in pharmacokinetic studies. J Chromatogr 584: 229-237.
30. Sullivan JP, McDonnell L, Hardiman OM, Farrell MA, Phillips JP and Tipton KF (1986) The oxidation of tryptamine by two forms of monoamine oxidase in human tissues. Biochem Pharmacol 35:3225-3260.
31. Tassaneeyakul W, Veronese ME, Birkett DJ, Gonzalez FJ and Miners JO (1993) Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochem Pharmacol 46:1975-1981.
32. Tiihonen J, Pesonen U, Kauhanen J, Koulu M, Hallikainen T, Leskinen L and Salonen JT (2000) CYP2A6 genotype and smoking. Mol Psychiatry 5:347-348.
33. Tyndale RF, Inaba T and Kalow W (1989) Evidence in human for variant allozymes of the nondeficient sparteine/debrisoquine monooxygenase (P450IID1) in vitro. Drug Metab Dispos 17:334-340.
34. Venkatakrishnan K, von Moltke LL and Greenblatt DJ (1998) Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of high affinity component as an index of CYPIA2 activity. J Pharm Sci 87:1502-1507.
35. von Moltke LL, Greenblatt DJ, Duan SX, Schmider J, Kudchadker L, Fogelman SM, Harmatz JS and Shader RI (1996) Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine. Psychopharmacology 128:398-407.
36. Wollmann H, Nilsson E, Antonin KH and Bieck PR (1985) Tryptamine kinetics in human volunteers, in Neuropsychopharmacology of Trace Amines (Boulton AA, Maitre L, Beiek PR and Reiderer P eds) pp 361-378, Humana Press, Clifton.
37. Yamano S, Tatsuno J and Gonzalez FJ (1990) The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29:1322-1329.
38. Yamazaki H, Inui Y, Yun CH, Guengerich FP and Shimada T (1992) Cytochrome P4502E1 and 2A6 enzyme as major catalysts for metabolic activation of n-nitrosodialkyf-amines and tobacco-relaled nitrosamines in human liver microsomes. Carcinogenesis 13:1789-1794.